Expert Review of Anticancer Therapy

Title Publication Date Language Citations
NECTIN-4 targeted theranostics for urothelial cancer: getting ready for primetime?2023/11/26English
Selective multimodal bladder-sparing therapy for muscle-invasive bladder cancer: the present and the future2023/09/27English
Treatment optimization in early triple negative breast cancer2023/10/03English
Shedding light on the side effects of immunotherapies used for leukemia: an updated review of the literature2023/10/09English
Prognostic value of circulating long non-coding RNAs in colorectal cancer patients: a meta-analysis2023/11/15English
Efficacy of third-generation epidermal growth factor receptor-tyrosine kinase inhibitors in advanced NSCLC with different T790M statuses tested via digital droplet polymerase chain reaction ddPCR and next-generation sequencing2024/04/02English
Comparative efficacy and safety of cabozantinib for malignant tumors: a systematic review and meta-analysis2024/04/01English
Neo-adjuvant therapies for ER positive/HER2 negative breast cancers: from chemotherapy to hormonal therapy, CDK inhibitors, and beyond2024/03/18English
Radiation therapy for triple-negative breast cancer: from molecular insights to clinical perspectives2024/03/21English
Drug–drug interaction potential among patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) treated with novel androgen receptor inhibitors2024/03/12English
Metastatic colorectal cancer- third line therapy and beyond2024/04/03English
Efficacy and safety of nivolumab plus ipilimumab versus nivolumab alone in patients with advanced melanoma: a systematic review and meta-analysis2024/03/29English
Development and validation of survival nomograms in elder triple-negative invasive ductal breast carcinoma patients2024/02/23English
Exploiting c-RAF dependency in RAS mutant cancer: beyond catalytic activity2024/02/26English
Utilizing clinical, pathological and radiological information to guide postoperative radiotherapy in prostate cancer2023/02/27English
LncRNA HCG11 enhances the chemosensitivity of non-small cell lung cancer cells to Gemcitabine via miR-17-5p/p21 axis2024/01/23English
Considerations regarding maintenance therapy for acute myeloid leukemia in remission2024/01/22English
Oral therapy for myelodysplastic syndromes/neoplasms and acute myeloid leukemia: a revolution in progress2023/07/20English
Impact of Quality Control Circle on Patient Outcomes after Hepatocellular Carcinoma Intervention: A Meta-Analysis2023/06/20English
Prostate and metastasis-directed focal therapy in prostate cancer: hype or hope?2023/02/01English
Navigating resistance to ALK inhibitors in the lorlatinib era: a comprehensive perspective on NSCLC2024/04/21English
How to manage prolonged immune effector cell-associated hematotoxicity (ICAHT) related to BCMA-directed myeloma therapy2024/04/21English
Are statins onco- suppressive agents for every type of tumor? A systematic review of literature2024/04/15English
Do treatment patterns differ in those with early-onset colorectal cancer?2024/04/15English
Novel oral selective estrogen receptor degraders (SERDs) to target hormone receptor positive breast cancer: elacestrant as the poster-child2024/04/26English
Hepatic artery infusion chemotherapy combined with the FOLFOX regimen for the treatment of hepatocellular carcinoma: recent advances and literature review2024/04/24English
Network meta-analysis of CAR T-Cell therapy for the treatment of 3L+ R/R LBCL after using published comparative studies2024/04/24English
The effect of age, sex, and eastern cooperative oncology group performance status on the efficacy and safety of immune checkpoint inhibitors in patients with hepatocellular carcinoma: a systematic review and meta-analysis2024/04/16English
Pediatric cancer care management during the COVID-19 pandemic: a review of the literature and a single-centre real-life experience of an Italian pediatric oncology unit2023/09/02English
Medullary thyroid carcinoma2023/08/30English